Even in patients with larger hypothalamic injury or lesions, GLP-1RAs appear to be efficient in reducing BMI, regulating appetite, and improving glycemic control
Five clinical trials in type 2-diabetic subjects (SURPASS 15) have shown that tirzepatide at 515 mg per week reduces both HbA 1c (1.24 to 2.58%) and body weight (5.411.7 kg) by amounts unprecedented for a single agent
Lets take someone that is older that gets put on these particular medications, and they develop girdle weakness because of the sarcopenia, and they develop muscle, and they havent diminished appropriately, so now they fall because of this, and they break a hip, so now weve taken one problem and created another problem, Fudickar said
Funding This research was supported by funds from Fondazione di Sardegna (2017), DR rep
Kushner, affirm that GLP-1 receptor agonists like semaglutide are effective tools for appetite regulation
Melatonin is most useful for circadian rhythm disruption and difficulty falling asleep, less so for middle-of-night awakenings